Anuska Llano

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Induced Pluripotent Stem Cells

Human Immunodeficiency Virus

Top Venues

Nature medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Miriam Rosás-Umbert, Jesper Damsgaard Gunst, Marie H Pahus, Rikke Olesen, Mariane Høgsbjerg Schleimann, Paul W Denton, Victor Ramos, Adam R Ward, Natalie N Kinloch, Dennis C Copertino, Tuixent Escribà, Anuska Llano, Zabrina L Brumme, R Brad Jones, Beatriz Mothe, Christian Brander, Julie M Fox, Michel C Nussenzweig, Sarah Fidler, Marina Caskey, Martin Tolstrup, Ole Schmeltz Søgaard
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8 + T cell immunity. Nature communications 13 (1) (2022)
Lucia Bailón, Anuska Llano, Samandhy Cedeño, Tuixent Escribà, Miriam Rosás-Umbert, Mariona Parera, Maria Casadellà, Miriam Lopez, Francisco Pérez, Bruna Oriol-Tordera, Marta Ruiz-Riol, Josep Coll, Felix Perez, Àngel Rivero, Anne R Leselbaum, Ian Michael McGowan, Devi Sengupta, Edmund G Wee, Tomáš Hanke, Roger Paredes, Yovaninna Alarcón-Soto, Bonaventura Clotet Sala, Marc Noguera-Julian, Christian Brander, Jose Molto, Beatriz Mothe, null null
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial. Nature medicine (2022)